← IDEXX LABORATORIES INC /DE
| Annual Trend | FY 2016 | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash flows from operating activities: | |||||||||||
| Adjustments to reconcile net income to net cash provided by operating activities: | |||||||||||
| Net Income (Loss) Attributable to Parent | $222.0m | $263.1m | $377.0m | $427.7m | $581.8m | $744.8m | $679.1m | $845.0m | $887.9m | $1.1b | |
| Net Income (Loss), Including Portion Attributable to Noncontrolling Interest | $222.1m | $263.3m | $377.0m | $427.8m | $582.1m | $744.8m | $679.1m | $845.0m | — | — | |
| Net Income (Loss) Attributable to Noncontrolling Interest | $9k | $125k | $16k | $72k | $355k | ($1k) | $0 | $0 | — | — | |
| Depreciation, Depletion and Amortization | $78.2m | $83.1m | $83.2m | $88.0m | $96.0m | $104.6m | $111.9m | $114.9m | $129.9m | $145.2m | |
| Amortization of Intangible Assets | $9.5m | $9.0m | $8.9m | $9.4m | $9.8m | $12.1m | $15.0m | $13.8m | $17.1m | $20.2m | |
| Other Depreciation and Amortization | $63.5m | $73.8m | $74.2m | $78.5m | $86.1m | $92.4m | $96.7m | $101.0m | $112.8m | $124.9m | |
| Deferred Income Tax Expense (Benefit) | $20.9m | ($7.9m) | $1.1m | $6.0m | ($36.7m) | ($3.4m) | ($34.9m) | ($48.3m) | ($24.2m) | $131.2m | |
| Share-based Payment Arrangement, Noncash Expense | $19.9m | $23.5m | $25.2m | $39.3m | $31.0m | $37.8m | $49.8m | $59.7m | $60.3m | $60.0m | |
| Payment, Tax Withholding, Share-based Payment Arrangement | — | $8.1m | $9.4m | $8.1m | $20.6m | $15.6m | $10.6m | $10.0m | $10.5m | $7.2m | |
| Share-based Payment Arrangement, Expense | $19.9m | $23.5m | $25.2m | $39.3m | $31.0m | $37.8m | $49.8m | $59.7m | $60.3m | $60.0m | |
| Goodwill, Impairment Loss | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | — | |
| Impairment of Intangible Assets (Excluding Goodwill) | — | $0 | $0 | $0 | — | $0 | $0 | $0 | $0 | $0 | |
| Impairment of Intangible Assets, Indefinite-lived (Excluding Goodwill) | $2.2m | — | — | — | — | — | — | — | — | — | |
| Income Tax Expense (Benefit) | $99.8m | $117.8m | $80.7m | $94.4m | $79.9m | $157.8m | $180.9m | $216.1m | $222.0m | $264.7m | |
| Interest Expense Nonoperating | — | — | — | — | — | — | — | — | $31.2m | $38.9m | |
| Operating Lease, Expense | — | — | — | $21.1m | $21.7m | $23.0m | $26.8m | $29.1m | $32.4m | $36.3m | |
| Changes in operating assets and liabilities: | |||||||||||
| Additional Financial Items | |||||||||||
| Increase (Decrease) in Accounts Receivable | $22.6m | $24.9m | $18.4m | $22.5m | $60.7m | $33.1m | $41.4m | $53.9m | $28.3m | $68.7m | |
| Increase (Decrease) in Inventories | ($7.6m) | $19.1m | $25.6m | $37.3m | $18.9m | $52.9m | $121.7m | $28.7m | $28.0m | $789k | |
| Increase (Decrease) in Accounts Payable | — | — | — | — | — | — | — | — | $8.1m | ($8.6m) | |
| Foreign Currency Transaction Gain (Loss), before Tax | ($1.3m) | $1.1m | ($3.1m) | ($1.1m) | $600k | ($2.1m) | ($3.4m) | ($1.1m) | ($4.5m) | ($4.2m) | |
| General and Administrative Expense | $207.0m | $220.9m | $244.9m | $261.3m | $300.8m | $309.7m | $326.2m | $335.8m | $442.3m | $404.8m | |
| Goodwill | $178.2m | $199.9m | $214.5m | $239.7m | $243.3m | $359.3m | $361.8m | $366.0m | $405.1m | $414.0m | |
| Operating Expenses | — | — | $750.2m | — | — | — | — | — | $1.3b | $1.3b | |
| Provision for Loan, Lease, and Other Losses | — | — | — | — | — | $1.5m | $5.8m | $5.6m | $6.9m | $8.4m | |
| Other Comprehensive Income (Loss), Reclassification Adjustment from AOCI on Derivatives, Net of Tax | $2.3m | ($197k) | — | — | — | — | — | — | — | — | |
| Net Cash Provided by (Used in) Operating Activities | $334.6m | $373.3m | $400.1m | $459.2m | $648.1m | $755.5m | $543.0m | $906.5m | $929.0m | $1.2b | |
| Cash flows from investing activities: | |||||||||||
| Payments to Acquire Property, Plant, and Equipment | $64.8m | $74.4m | $115.8m | $155.0m | $107.0m | $119.5m | $148.8m | $133.6m | $120.9m | $124.7m | |
| Payments to Acquire Businesses, Net of Cash Acquired | $2.0m | $14.6m | $22.5m | $50.3m | $1.5m | $173.4m | $11.5m | $0 | $76.7m | $0 | |
| Net Cash Provided by (Used in) Investing Activities | ($90.8m) | ($138.7m) | $138.6m | ($205.5m) | ($109.4m) | ($293.0m) | ($195.3m) | ($125.3m) | ($207.1m) | ($136.2m) | |
| Cash flows from financing activities: | |||||||||||
| Payments for Repurchase of Common Stock | $304.1m | $282.6m | $369.3m | $301.7m | $182.8m | $746.8m | $819.7m | $71.9m | $837.0m | $1.2b | |
| Net Cash Provided by (Used in) Financing Activities | ($217.8m) | ($208.0m) | ($597.8m) | ($286.4m) | ($248.4m) | ($697.4m) | ($370.9m) | ($442.0m) | ($878.1m) | ($1.2b) | |
| Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents | ($54k) | $6.2m | ($4.8m) | ($689k) | $3.3m | ($4.6m) | ($8.6m) | $2.1m | ($9.5m) | $11.2m | |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect | $25.9m | $32.8m | ($63.9m) | ($33.5m) | $293.6m | ($239.5m) | ($31.9m) | $341.4m | ($165.7m) | ($108.2m) | |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents | — | — | — | $90.3m | $383.9m | $144.5m | $112.5m | $453.9m | $288.3m | $180.1m | |
| Supplemental disclosure of cash flow information: | |||||||||||
| Interest Paid, Excluding Capitalized Interest, Operating Activities | $31.0m | $37.6m | $34.7m | $29.7m | $32.4m | $30.5m | $39.5m | $41.0m | $33.8m | $37.7m | |
| Income Taxes Paid, Net | $74.7m | $81.2m | $69.7m | $88.0m | $110.7m | $161.7m | $239.8m | $192.5m | $307.2m | $167.5m |
Values abbreviated: b = billions, m = millions, k = thousands. Per share data in USD.